Health Care/Hospital

Multi-Billion Dollar Health Insurance Company Improves Efficiency of Remote Contact Center Workforce with Bright Pattern

A large health insurance company provides personalized outreach with improved remote agent capabilities while eliminating downtime with new self-diagnosis features that resolve remote workforce connectivity issues SOUTH SAN FRANCISCO, Calif., March 10, 2021 /PRNewswire/ -- Bright Pattern, a lead...

2021-03-10 01:05 2952

Hyperice Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021

Recovery Technology Leader Among Top-Ranked in the Sports Category IRVINE, Calif., March 9, 2021 /PRNewswire/ -- Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air compression and thermal technology, has been named toFast Company's prestigious ...

2021-03-09 22:02 2642

Genome and Company signs second clinical trial collaboration and supply agreement (Phase 2) with Merck KGaA, Darmstadt, Germany and Pfizer for immuno-oncology microbiome study

* Genome and Company expands collaboration with Merck KGaA, Darmstadt, Germany and Pfizer for further clinical combination study of GEN-001 in gastric cancers * Establishment of the efficient "clinical development strategy" for the global immuno-oncology microbiome treatment SEOUL, South Korea,...

2021-03-09 22:00 2939

Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs

HONG KONG, March 9, 2021 /PRNewswire/ -- Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico'sChemistry42™ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the...

2021-03-09 22:00 2070

Novartis receives approval for Kymriah (tisagenlecleucel) by Health Sciences Authority as Singapore's first commercially approved CAR-T therapy

* Kymriah, the first chimeric antigen receptor T-cell (CAR-T) therapy approved inSingapore, is indicated as a one-time treatment manufactured individually for each patient. * Novartis works closely with qualified centres to deliver this treatment for eligible relapsed/refractory (r/r) pediatr...

2021-03-09 20:12 6238

Enterprise Digital Imaging to Help Healthcare Providers Future-proof their IT Strategy

Providers want to deploy a scalable platform that can manage clinical and operational workflows, secure data and aid in precision diagnoses, finds Frost & Sullivan SANTA CLARA, Calif., March 9, 2021 /PRNewswire/ -- With digital health becoming mainstream, healthcare professionals have to manage ...

2021-03-09 20:02 1170

Caris' Precision Oncology Alliance Continues to Grow Internationally as it Welcomes Curie Oncology from Singapore

Curie Oncology expands Caris' collaborative network of oncology institutions focused on research into personalized therapies through precision medicine IRVING, Texas, March 9, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused o...

2021-03-09 19:30 1576

HKBN Enterprise Solutions Offers Prompt Support to Catering Businesses with PHILIPS UV-C Air Disinfection Device

HONG KONG, March 9, 2021 /PRNewswire/ -- Understanding the special operational needs of catering businesses during COVID, HKBN Enterprise Solutions ("HKBNES") has teamed up with Signify (formerly Philips Lighting) to bring to the market – in particular restaurants and catering premises –PHILIPS U...

2021-03-09 16:29 2451

Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021

LONDON, March 9, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of its annual "Drugs to Watch" list, identifying drugs entering the market or launching key indications i...

2021-03-09 16:00 3186

Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index

- A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation - There is a strong cor...

2021-03-09 15:00 2067

Ping An AskBob Doctor's Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI

HONG KONG and SHANGHAI, March 9, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) is pleased to announce that promising research on the artificial intelligence (AI) technology of Ping An AskBob Doctor has been publi...

2021-03-09 14:57 6748

Entire industrial chain resources of advanced medical equipment are lining up at Medtec China 2021

SHANGHAI, March 8, 2021 /PRNewswire/ -- The advanced medical equipment industry chain includes various fields, such as materials, design, components, parts manufacturing, and complete machine manufacturing. Each field may lead to several subdivisions, where high scientific and technological insig...

2021-03-09 09:30 2292

FASN Inhibitor ASC40 Demonstrates Positive Phase 2 Topline Clinical Results from China Cohort of Patients with NASH

* Oral FASN inhibitor ASC40 shown to meaningfully reduce liver fat with a 50% responder rate * Consistent improvement in biomarkers of liver inflammation as observed in U.S. cohort SHANGHAI, China and SAN MATEO, California, March 9, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly-owned...

2021-03-09 08:30 6467

proteanTecs Joins the TSMC IP Alliance Program

HAIFA, Israel, March 9, 2021 /PRNewswire/ -- proteanTecs, a leading provider of health and performance monitoring solutions for advanced electronics, today announced it has joined the TSMC IP Alliance Program, a key component of TSMC's Open Innovation Platform® (OIP). The alliance includes major ...

2021-03-09 08:01 1870

Comvita launches Special Reserve Manuka and OneHive movement

TAURANGA, New Zealand, March 9, 2021 /PRNewswire/ -- Comvita, the global leader in Manuka Honey, has today launched its limited-edition Special Reserve UMF™ 25+ (MGO 1200+) Manuka Honey, carefully collecting some of the world's rarest honey to create a moment of delicious pleasure that connects p...

2021-03-09 03:05 6369

Global Covid-19 Vaccination Roll-out causes delay to RhoVac's Phase IIb study

STOCKHOLM, March 9, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,March 8th , 2021, that its clinical phase IIb study, "BRaVac", in prostate cancer, will be somewhat further delayed as Covid-19 vaccinations are rolled out to the study populatio...

2021-03-09 02:41 1364

AMD Telemed Applauded by Frost & Sullivan for Its Modular Engage N' Solution that Supports Patient Needs by Acuity Level

AMD's unified virtual care framework connects interoperable electronic health records, medical devices, and various engagement models to offer exceptional value to clients SANTA CLARA, Calif., March 9, 2021 /PRNewswire/ -- Based on its recent analysis of the North American virtual care market,Fr...

2021-03-09 01:12 1321

Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology

With scalable, advanced resource and technology capabilities, Tergus presents pharma companies with exceptional CRO services for all their drug discovery and development requirements SANTA CLARA, Calif., March 8, 2021 /PRNewswire/ -- Based on its recent analysis of the North American contract re...

2021-03-08 22:00 1442

Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer

ST. LOUIS, March 8, 2021 /PRNewswire/ -- Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, today announced that it has entered into an exclusive license and collaboration agreement withShanghai-based...

2021-03-08 22:00 2752

Ortho's New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative Results

- Ortho's new VITROS® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS® Anti-SARS-CoV-2 IgG 2 Antibody assay receive CE Mark - Both tests can aid in identifying individuals with an adaptive immune response (acquired naturally or through vaccination) to SARS-CoV-2 - These new anti-SARS-CoV-2 ant...

2021-03-08 21:00 3051
1 ... 349350351352353354355 ... 551

Week's Top Stories